Skip to main content
Premium Trial:

Request an Annual Quote

Reagent Firm Active Motif Acquires TimeLogic

NEW YORK, Aug. 26 (GenomeWeb News) - Active Motif, a Carlsbad, Calif.-based provider of cell biology reagents, said today that it has acquired TimeLogic in a stock deal for an undisclosed price.

 

TimeLogic will move from Crystal Bay, Nev., to Carlsbad and will continue to use the registered trade name "DeCypher" for its accelerated sequence analysis platform, the company said.

 

"By helping connect wet lab science with computational biology methods, we see an excellent opportunity for Active Motif to help TimeLogic's customers," said John Archdeacon, head of R&D for Active Motif, in a statement.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.